Literature DB >> 21773878

Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up.

Anniken Hamang1, Geir Egil Eide, Berit Rokne, Karin Nordin, Cathrine Bjorvatn, Nina Øyen.   

Abstract

Since Long QT syndrome and Hypertrophic cardiomyopathy are inherited cardiac disorders that may cause syncope, palpitations, serious arrhythmias, and sudden cardiac death, at-risk individuals may experience heart-focused anxiety. In a prospective multi-site study, 126 Norwegian patients attending genetic counseling were followed 1 year with multiple administration of questionnaires, including the Cardiac Anxiety Questionnaire, measuring three distinct symptoms of heart-focused anxiety- avoidance, attention, and fear-in mixed linear analyses. Overall, at 1-year follow-up, patients with clinical diagnosis as compared to patients at genetic risk had significantly higher scores of avoidance (p < .002), attention (p < .005), and fear (p < .007). Sudden cardiac death in close relatives, uncertainty whether other relatives previously had undergone genetic testing, patients' perceived general health, self-efficacy expectations and procedural satisfaction with genetic counseling were influential in predicting the different symptoms of heart-focused anxiety over time.

Entities:  

Mesh:

Year:  2011        PMID: 21773878     DOI: 10.1007/s10897-011-9393-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  43 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Heart-focused and general illness fears in relation to parental medical history and separation experiences.

Authors:  G H Eifert; J P Forsyth
Journal:  Behav Res Ther       Date:  1996-09

3.  Perceived health among individuals with panic disorder: associations with affective vulnerability and psychiatric disability.

Authors:  Kristin L Gregor; Michael J Zvolensky; Andrew R Yartz
Journal:  J Nerv Ment Dis       Date:  2005-10       Impact factor: 2.254

4.  Short form 36 (SF-36) health survey: normative data from the general Norwegian population.

Authors:  J H Loge; S Kaasa
Journal:  Scand J Soc Med       Date:  1998-12

5.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

Review 6.  Cardiophobia: a paradigmatic behavioural model of heart-focused anxiety and non-anginal chest pain.

Authors:  G H Eifert
Journal:  Behav Res Ther       Date:  1992-07

7.  Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death.

Authors:  Janice Andersen; Nina Øyen; Cathrine Bjorvatn; Eva Gjengedal
Journal:  J Genet Couns       Date:  2008-08-22       Impact factor: 2.537

Review 8.  [Genetic counseling in congenital long QT syndrome].

Authors:  Anniken Hamang; Berge Solberg; Cathrine Bjorvatn; Gottfried Greve; Nina Øyen
Journal:  Tidsskr Nor Laegeforen       Date:  2009-06-11

Review 9.  Congenital long QT syndrome.

Authors:  Lia Crotti; Giuseppe Celano; Federica Dagradi; Peter J Schwartz
Journal:  Orphanet J Rare Dis       Date:  2008-07-07       Impact factor: 4.123

10.  Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population.

Authors:  Anniken Hamang; Geir Egil Eide; Karin Nordin; Berit Rokne; Cathrine Bjorvatn; Nina Øyen
Journal:  BMC Med Genet       Date:  2010-02-17       Impact factor: 2.103

View more
  6 in total

1.  Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.

Authors:  Amirah Khouzam; Andrea Kwan; Samantha Baxter; Jonathan A Bernstein
Journal:  J Genet Couns       Date:  2015-01-08       Impact factor: 2.537

2.  Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability.

Authors:  Corline Brouwers; Kadir Caliskan; Sven Bos; Jeanine E Roeters Van Lennep; Eric J Sijbrands; Willem J Kop; Susanne S Pedersen
Journal:  Int J Behav Med       Date:  2015-12

3.  Heart-Focused Anxiety Affects Behavioral Cardiac Risk Factors and Quality of Life: A Follow-Up Study Using a Psycho-Cardiological Rehabilitation Concept.

Authors:  Christoph Schmitz; Sonja Maria Wedegärtner; Eike Langheim; Judit Kleinschmidt; Volker Köllner
Journal:  Front Psychiatry       Date:  2022-05-09       Impact factor: 5.435

4.  Minding the Genes: a Multidisciplinary Approach towards Genetic Assessment of Cardiovascular Disease.

Authors:  Ashley Rhodes; Lindsey Rosman; John Cahill; Jodie Ingles; Brittney Murray; Crystal Tichnell; Cynthia A James; Samuel F Sears
Journal:  J Genet Couns       Date:  2016-09-30       Impact factor: 2.537

5.  Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study.

Authors:  Catherine McGorrian; Charlene McShane; Colin McQuade; Ted Keelan; Jim O Neill; Joseph Galvin; Kevin Malone; Niall G Mahon; Mary Codd
Journal:  BMC Med Genet       Date:  2013-01-08       Impact factor: 2.103

6.  General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety- a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death.

Authors:  Anniken Hamang; Geir E Eide; Berit Rokne; Karin Nordin; Nina Øyen
Journal:  Health Qual Life Outcomes       Date:  2011-11-14       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.